An agreement between the Google[x] resesearch lab and pharmaceutical giant Novartis will license the technology for actual medical use for people with diabetes and other conditions.
The companies are seeking ways to integrate health sensors and apps into their wearable devices, including those to measure glucose levels in a non-invasive way.
What if people with diabetes didn't have to prick their fingers several times a day to conduct blood sugar tests -- but instead could simply wear contacts?
Google is developing a "smart" contact lens to monitor blood sugar levels through the wearer's tears.
Scientists at Stanford are working on a vaccine to stop a type 1 diabetic's immune system from attacking the cells that make insulin.
Diabetics can have a "fruity" odor to their breath that indicates high glucose levels, and chemists at the University of Pittsburgh say this biomarker alone can diagnose the disease.
Diabetics are being warned that Apple's Health app is not compatible with some blood glucose measurements, meaning those in the UK and Australia could see inaccurate readings.
The two companies have collided on everything from drones to acquisitions to search. And the competition between the tech titans isn't slowing down.
Nanotechnology could remove the finger prick from the daily routine of people with diabetes with an injectable gel that monitors blood-sugar levels and automatically secretes insulin.
The head of the Google division that makes Glass talks about the challenges of wearables, and why putting a computing device on your body is "a big ask."